New treatment may aid diabetes patients
Source: Agencies |
February 6, 2010, Saturday
|
Print Edition
Print Edition
SCIENTISTS have used an "artificial pancreas" system of pumps and monitors to improve blood sugar control in diabetes patients in the first study to show the new device works better than conventional treatment.
Researchers from Britain's Cambridge University tested the device on 17 children with type 1 diabetes during a series of nights in hospital and found it kept their blood sugar levels within the important "normal" range for 60 percent of the time.
The new system, which involves patients wearing a matchbox-sized monitor and a similar-sized pump with a tube to deliver insulin into the body, also halved the amount of time blood sugar dropped to worrying or dangerous levels, they said.
Medical device makers have been working for years to develop a so-called artificial pancreas to deliver insulin to patients with type 1 diabetes, an autoimmune disease in which the body destroys its own ability to make insulin.
The bodies of type 1 diabetes sufferers become unable to properly break down sugar and if untreated, blood vessels and nerves are destroyed, organs fail and patients die.
"These devices could transform the management of type 1 diabetes," said Roman Hovorka of Cambridge, who led the research.
He said the results were "an important stepping stone" toward bringing an artificial pancreas to the commercial market, but predicted several years yet of refinement before it could be used by patients in normal life.
"It's a bit like with mobile phones. When we started, the technology wasn't very good and the functionality was limited, and it took a number of generations to move to the device that we have now. I see the same thing with this system."
The Juvenile Diabetes Research Foundation said last month it was teaming up with US-based drug maker Johnson & Johnson's unit Animas and DexCom Inc to develop and test an artificial pancreas system.
Researchers from Britain's Cambridge University tested the device on 17 children with type 1 diabetes during a series of nights in hospital and found it kept their blood sugar levels within the important "normal" range for 60 percent of the time.
The new system, which involves patients wearing a matchbox-sized monitor and a similar-sized pump with a tube to deliver insulin into the body, also halved the amount of time blood sugar dropped to worrying or dangerous levels, they said.
Medical device makers have been working for years to develop a so-called artificial pancreas to deliver insulin to patients with type 1 diabetes, an autoimmune disease in which the body destroys its own ability to make insulin.
The bodies of type 1 diabetes sufferers become unable to properly break down sugar and if untreated, blood vessels and nerves are destroyed, organs fail and patients die.
"These devices could transform the management of type 1 diabetes," said Roman Hovorka of Cambridge, who led the research.
He said the results were "an important stepping stone" toward bringing an artificial pancreas to the commercial market, but predicted several years yet of refinement before it could be used by patients in normal life.
"It's a bit like with mobile phones. When we started, the technology wasn't very good and the functionality was limited, and it took a number of generations to move to the device that we have now. I see the same thing with this system."
The Juvenile Diabetes Research Foundation said last month it was teaming up with US-based drug maker Johnson & Johnson's unit Animas and DexCom Inc to develop and test an artificial pancreas system.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
